These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18566026)

  • 21. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis.
    Benedetti B; Rovaris M; Rocca MA; Caputo D; Zaffaroni M; Capra R; Bertolotto A; Martinelli V; Comi G; Filippi M
    Mult Scler; 2009 Jul; 15(7):789-94. PubMed ID: 19465450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuromyelitis optica in Brazil: a study on clinical and prognostic factors.
    Bichuetti DB; Oliveira EM; Souza NA; Rivero RL; Gabbai AA
    Mult Scler; 2009 May; 15(5):613-9. PubMed ID: 19299436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway.
    Glad SB; Nyland HI; Aarseth JH; Riise T; Myhr KM
    Mult Scler; 2009 Aug; 15(8):942-50. PubMed ID: 19570821
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Magnetic resonance evidence of cortical onset of multiple sclerosis.
    Calabrese M; Gallo P
    Mult Scler; 2009 Aug; 15(8):933-41. PubMed ID: 19667021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vanishing MS T2-bright lesions before puberty: a distinct MRI phenotype?
    Chabas D; Castillo-Trivino T; Mowry EM; Strober JB; Glenn OA; Waubant E
    Neurology; 2008 Sep; 71(14):1090-3. PubMed ID: 18824673
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accumulation of cortical lesions in MS: relation with cognitive impairment.
    Roosendaal SD; Moraal B; Pouwels PJ; Vrenken H; Castelijns JA; Barkhof F; Geurts JJ
    Mult Scler; 2009 Jun; 15(6):708-14. PubMed ID: 19435749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Accuracy of CSF and MRI criteria for dissemination in space in the diagnosis of multiple sclerosis.
    Villar LM; García-Barragán N; Sádaba MC; Espiño M; Gómez-Rial J; Martínez-San Millán J; González-Porqué P; Alvarez-Cermeño JC
    J Neurol Sci; 2008 Mar; 266(1-2):34-7. PubMed ID: 17884100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring demyelination and remyelination in acute multiple sclerosis lesion voxels.
    Giacomini PS; Levesque IR; Ribeiro L; Narayanan S; Francis SJ; Pike GB; Arnold DL
    Arch Neurol; 2009 Mar; 66(3):375-81. PubMed ID: 19273757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M; Uyttenboogaart M; van Harten A; De Keyser J
    Mult Scler; 2008 Jul; 14(6):799-803. PubMed ID: 18573840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Measures in the first year of therapy predict the response to interferon beta in MS.
    Río J; Castilló J; Rovira A; Tintoré M; Sastre-Garriga J; Horga A; Nos C; Comabella M; Aymerich X; Montalbán X
    Mult Scler; 2009 Jul; 15(7):848-53. PubMed ID: 19542263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor PASAT performance correlates with MRI contrast enhancement in multiple sclerosis.
    Bellmann-Strobl J; Wuerfel J; Aktas O; Dörr J; Wernecke KD; Zipp F; Paul F
    Neurology; 2009 Nov; 73(20):1624-7. PubMed ID: 19917984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients' stratification and correlation of brain magnetic resonance imaging parameters with disability progression in multiple sclerosis.
    Vaneckova M; Seidl Z; Krasensky J; Havrdova E; Horakova D; Dolezal O; Burgetova A; Masek M
    Eur Neurol; 2009; 61(5):278-84. PubMed ID: 19295214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for relative cortical sparing in benign multiple sclerosis: a longitudinal magnetic resonance imaging study.
    Calabrese M; Filippi M; Rovaris M; Bernardi V; Atzori M; Mattisi I; Favaretto A; Grossi P; Barachino L; Rinaldi L; Romualdi C; Perini P; Gallo P
    Mult Scler; 2009 Jan; 15(1):36-41. PubMed ID: 18755823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple sclerosis: relapses and timing of remissions.
    Iuliano G; Napoletano R; Esposito A
    Eur Neurol; 2008; 59(1-2):44-8. PubMed ID: 17917457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of treatment of MS with IFNbeta-1b or glatiramer acetate by monthly brain MRI in the BECOME study.
    Cadavid D; Wolansky LJ; Skurnick J; Lincoln J; Cheriyan J; Szczepanowski K; Kamin SS; Pachner AR; Halper J; Cook SD
    Neurology; 2009 Jun; 72(23):1976-83. PubMed ID: 19279320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative assessment of brain iron by R(2)* relaxometry in patients with clinically isolated syndrome and relapsing-remitting multiple sclerosis.
    Khalil M; Enzinger C; Langkammer C; Tscherner M; Wallner-Blazek M; Jehna M; Ropele S; Fuchs S; Fazekas F
    Mult Scler; 2009 Sep; 15(9):1048-54. PubMed ID: 19556316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can rate of brain atrophy in multiple sclerosis be explained by clinical and MRI characteristics?
    Korteweg T; Rovaris M; Neacsu V; Filippi M; Comi G; Uitdehaag BM; Knol DL; Polman CH; Barkhof F; Vrenken H;
    Mult Scler; 2009 Apr; 15(4):465-71. PubMed ID: 19091881
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
    Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-life impact of early interferon beta therapy in relapsing multiple sclerosis.
    Trojano M; Pellegrini F; Paolicelli D; Fuiani A; Zimatore GB; Tortorella C; Simone IL; Patti F; Ghezzi A; Zipoli V; Rossi P; Pozzilli C; Salemi G; Lugaresi A; Bergamaschi R; Millefiorini E; Clerico M; Lus G; Vianello M; Avolio C; Cavalla P; Lepore V; Livrea P; Comi G; Amato MP;
    Ann Neurol; 2009 Oct; 66(4):513-20. PubMed ID: 19847899
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
    Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
    J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.